$143.53
1.52% yesterday
NYSE, May 20, 10:10 pm CET
ISIN
US1598641074
Symbol
CRL

Charles River Laboratories International, Inc. Stock price

$143.53
+40.86 39.80% 1M
-44.37 23.61% 6M
-41.07 22.25% YTD
-79.53 35.65% 1Y
-89.11 38.30% 3Y
-32.33 18.38% 5Y
+71.09 98.14% 10Y
NYSE, Closing price Tue, May 20 2025
+2.15 1.52%
ISIN
US1598641074
Symbol
CRL
Sector
Industry

Key metrics

Market capitalization $7.05b
Enterprise Value $9.86b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 17.50
EV/Sales (TTM) EV/Sales 2.45
P/S ratio (TTM) P/S ratio 1.75
P/B ratio (TTM) P/B ratio 2.21
Revenue growth (TTM) Revenue growth -2.16%
Revenue (TTM) Revenue $4.02b
EBIT (operating result TTM) EBIT $514.89m
Free Cash Flow (TTM) Free Cash Flow $563.24m
Cash position $230.26m
EPS (TTM) EPS $-0.65
P/E forward 32.28
P/S forward 1.82
EV/Sales forward 2.54
Short interest 6.19%
Show more

Is Charles River Laboratories International, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Charles River Laboratories International, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Charles River Laboratories International, Inc. forecast:

5x Buy
25%
14x Hold
70%
1x Sell
5%

Analyst Opinions

20 Analysts have issued a Charles River Laboratories International, Inc. forecast:

Buy
25%
Hold
70%
Sell
5%

Financial data from Charles River Laboratories International, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4,023 4,023
2% 2%
100%
- Direct Costs 2,798 2,798
2% 2%
70%
1,224 1,224
10% 10%
30%
- Selling and Administrative Expenses 312 312
25% 25%
8%
- Research and Development Expense - -
-
-
912 912
4% 4%
23%
- Depreciation and Amortization 397 397
23% 23%
10%
EBIT (Operating Income) EBIT 515 515
18% 18%
13%
Net Profit -32 -32
107% 107%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Charles River Laboratories International, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Charles River Laboratories International, Inc. Stock News

Neutral
Business Wire
8 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Bank of America Health Care Conference.
Positive
CNBC
11 days ago
The firm has three possible paths toward value creation at the drug development company.
Neutral
Investopedia
13 days ago
The S&P 500 broke a two-session losing streak, rising Wednesday as stocks gained ground in volatile trading following the Federal Reserve's decision to keep interest rates unchanged.
More Charles River Laboratories International, Inc. News

Company Profile

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Head office United States
CEO James Foster
Employees 20,100
Founded 1947
Website www.criver.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today